HWMA
HZNP

Heritage Wealth Management (Arizona)’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Heritage Wealth Management (Arizona)’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$1.37K Buy
12
+6
+100% +$498 ﹤0.01% 1002
2022
Q3 		$0 Buy
+6
New +$419 ﹤0.01% 1129

Other funds holding HZNP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Heritage Wealth Management (Arizona)'s HZNP Position: Q4 2022 in Review

Heritage Wealth Management (Arizona) increased its Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) stake by 100% in Q4 2022, buying an estimated $498 and bringing the position to 12 shares worth $1.37K. The position accounts for ﹤0.01% of the portfolio, ranked #1002.

Heritage Wealth Management (Arizona) first reported a position in HZNP in Q3 2022 and has held it in 2 quarters since. 615 funds tracked by Wall St. Rank hold HZNP as of Q4 2022.

  • Heritage Wealth Management (Arizona) held 12 shares of Horizon Therapeutics Public Limited Company Ordinary Shares worth $1.37K as of Q4 2022.
  • Heritage Wealth Management (Arizona) bought 6 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2022, an estimated $498.
  • Horizon Therapeutics Public Limited Company Ordinary Shares made up ﹤0.01% of Heritage Wealth Management (Arizona)'s portfolio in Q4 2022, its #1002 holding.
  • Heritage Wealth Management (Arizona) first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2022 and has held it in 2 quarters since.
  • 615 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2022.

Based on Heritage Wealth Management (Arizona)'s 13F filing for Q4 2022, filed 13 Feb 2023.